alpha-Adrenergic Agonist Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: alpha-Adrenergic Agonist
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 204640-001 | Dec 18, 2013 | AP | RX | Yes | Yes | 10,130,592 | ⤷ Try for Free | Y | ⤷ Try for Free | ||
Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-003 | Apr 21, 2023 | RX | Yes | Yes | 12,133,837 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 204200-001 | Dec 7, 2012 | RX | Yes | Yes | 9,119,876 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-001 | Apr 21, 2023 | RX | Yes | Yes | 11,207,280 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |